NMRA: Neumora Therapeutics, Inc. Stock

by  •  • Comments Off on NMRA: Neumora Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 147.94
Enterprise Value ($M) 5.79
Book Value ($M) 287.06
Book Value / Share 1.77
Price / Book 0.52
NCAV ($M) 284.15
NCAV / Share 1.75
Price / NCAV 0.52

Profitability (mra)
Return on Invested Capital (ROIC) -0.84
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 10.51
Current Ratio 10.51

Balance Sheet (mrq) ($M)
Current Assets 314.06
Assets 316.97
Liabilities 29.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -263.46
Net Income -243.79
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -182.94
Cash from Investing -70.56
Cash from Financing 21.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Berns Paul L 5.10 3.03
11-22 13D/A ARCH Venture Fund XII, L.P. 19.80 0.04
11-12 13G Softbank Group Corp 4.70 -1.31
07-08 13G Fmr Llc 5.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-02 416,080 907,669 45.84
2025-04-01 341,387 1,016,642 33.58
2025-03-31 544,674 1,268,601 42.94
2025-03-28 119,256 439,588 27.13

(click for more detail)

Similar Companies
NBIX – Neurocrine Biosciences, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc.


Financial data and stock pages provided by
Fintel.io